Alteration in endothelial estrogen receptor expression: a potential key of vasculoprotection by estrogens?
Arnal
Jean-François
JF
Bayard
Francis
F
D000818:Animals; D001161:Arteriosclerosis / Q000209:etiology / Q000378:metabolism; D001808:Blood Vessels / Q000187:drug effects; D001943:Breast Neoplasms / Q000139:chemically induced; D002478:Cells, Cultured; D019610:Cytoprotection / Q000187:drug effects*; D004195:Disease Models, Animal; D004359:Drug Therapy, Combination; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism*; D004958:Estradiol / Q000494:pharmacology; D004967:Estrogens / Q000009:adverse effects / Q000494:pharmacology*; D005260:Female; D005500:Follow-Up Studies; D005786:Gene Expression Regulation / Q000187:drug effects; D020249:Hormone Replacement Therapy / Q000009:adverse effects; D006801:Humans; D051379:Mice; D009569:Nitric Oxide / Q000378:metabolism; D017698:Postmenopause; D011372:Progestins / Q000009:adverse effects / Q000494:pharmacology; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D011960:Receptors, Estrogen / Q000235:genetics / Q000378:metabolism*; D018570:Risk Assessment; D012756:Sheep
D004967:Estrogens; D011372:Progestins; D011960:Receptors, Estrogen; D009569:Nitric Oxide; D004958:Estradiol